COVID-19 testing in India in comparison to the rest of the world. If Indian testing strategy was replicated in the other top 15 COVID-19 affected countries in the world, the status would be startlingly different

Author:

Parikh Purvish M.1,Bapna Ajay2,Krishna M. Vamshi3,Mehta Prashant4,Aggarwal Shyam5,Gulia Ashish6

Affiliation:

1. Department of Oncology, Shalby Hospital, Mumbai, Maharashtra, India,

2. Department of Medical Oncology, Bhagwan Mahaveer Cancer Hospital, Jaipur, Rajasthan, India,

3. Department of Medical Oncology and Hematology, Apollo Cancer Institutes, Hyderabad, Telangana, India,

4. Department of Medical Oncology/Hematoncology/BMT, Asian Institute of Medical Sciences, Faridabad, Haryana, India,

5. Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India,

6. Bone and Soft Tissue, Tata Memorial Hospital, Mumbai, Maharashtra, India,

Abstract

In terms of the absolute number of COVID-19 positive cases, India is among the top four countries in the world. There is a lot of unwarranted criticism about the alleged inadequacy of COVID-19 testing in India. The facts available from international and publicly available online non-government source covering the entire world show otherwise. While India is fourth in terms of an absolute number of cases, its rank is 132nd in terms of cases per million population and 107th for deaths per million population. These are indications that India is doing much better in the battle against COVID-19 than it is getting credit for. The correct benchmark for the adequacy of testing is the percentage of COVID-19 positive results as compared to the total number of tests performed. India ranks 5th (out of 215) in this respect – being better than some western countries such as the USA, Spain, and France. Thus, the Indian strategy for COVID-19 testing is better and more appropriate than the majority of other countries with the large absolute number of positive cases.

Publisher

Scientific Scholar

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Universal health coverage mitigated COVID-19 health-related consequences in Asia Oceania;International Journal of Disaster Risk Reduction;2023-06

2. Resurgence of COVID-19 in India - Challenges and solution;Indian Journal of Medical Sciences;2021-05-29

3. Severe acute respiratory syndrome coronavirus 2: Mutations and variants of concern – the Indian scenario;International Journal of Molecular & Immuno Oncology;2021-05-29

4. Why Is China Importing COVID-19 Vaccine Now?;Indian Journal of Medical and Paediatric Oncology;2021-03

5. Increase in Cancer Patient Load during COVID-19 Pandemic: The Faridabad Experience;South Asian Journal of Cancer;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3